Transcriptional control: an essential component of cancer gene therapy strategies?
- 15 November 2000
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 44 (2-3) , 167-184
- https://doi.org/10.1016/s0169-409x(00)00093-4
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Nonviral gene therapy: promises and challengesGene Therapy, 2000
- In vivo expression of prostate-specific adenoviral vectors in a canine modelCancer Gene Therapy, 1999
- Augmentation of Melanoma-Specific Gene Expression Using a Tandem Melanocyte-Specific Enhancer Results in Increased Cytotoxicity of the Purine Nucleoside Phosphorylase Gene in MelanomaHuman Gene Therapy, 1999
- Development and application of adenoviral vectors for gene therapy of cancerCancer Gene Therapy, 1999
- Effective and safe gene therapy for colorectal carcinoma using the cytosine deaminase gene directed by the carcinoembryonic antigen promoterGene Therapy, 1999
- Viral Vectors for Gene TherapyPharmacology & Therapeutics, 1998
- Relative activity and specificity of promoters from prostate-expressed genesThe Prostate, 1998
- Progress in Transcriptionally Targeted and Regulatable Vectors for Genetic TherapyHuman Gene Therapy, 1997
- Tissue-Specific Gene Expression from Mo-MLV Retroviral Vectors with Hybrid LTRs Containing the Murine Tyrosinase Enhancer/PromoterVirology, 1995
- Targeting of cytokine gene expression to malignant melanoma cells using tissue specific promoter sequencesAnnals of Oncology, 1994